KJT

KJT

Strategic evidence generation for life sciences

Overview

KJT is a life sciences-focused partner that provides tailored evidence generation and medical communications throughout a product’s lifecycle. Its main function is to help life sciences companies generate the data and messaging needed to support research, regulatory, commercialization, and ongoing medical communications, using customized strategies rather than a one-size-fits-all approach. Unlike firms that offer generic services, KJT aims to be a strategic partner—working closely with clients across the entire lifecycle to align research, evidence, and communication with business goals. The overarching goal is to positively impact its clients’ businesses to improve healthcare globally.

About KJT

Simplify's Rating
Why KJT is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Consulting

Biotechnology

Healthcare

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Rochester, New York

Founded

2007

Get referred to KJT

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • KJT added Jason Solack in 2026, signaling continued operational scaling.
  • KJT's DialogueDx uses generative AI to analyze patient-provider conversations for faster insight delivery.
  • KJT keeps hiring senior leaders in 2025-2026, including Melissa Usseglio and Katherine Ephlin.

What critics are saying

  • KJT relies on life sciences budgets; pharma cuts can crush utilization within one quarter.
  • Sparq's AI features face fast-following copycats from consultancies with larger data and engineering teams.
  • If KJT loses scientific credibility on AI outputs, healthcare clients can abandon the platform entirely.

What makes KJT unique

  • KJT Group is 100% employee-owned and certified women-owned, aligning incentives tightly.
  • KJT specializes exclusively in healthcare, especially pharmaceuticals, biotechnology, rare disease, and RWE.
  • KJT integrated Sparq Intelligence into core offerings in February 2026, adding AI predictive research.

Help us improve and share your feedback! Did you find this helpful?

Company News

Elevate Healthcare
Dec 4th, 2024
Rare Disease Revolution: Access, Advocacy, and Amplification of the Patient Voice

Cofounder Lorna Weir joins KJT panel to discuss amplifying the voice of rare disease patient.

KJT Group
Oct 21st, 2024
KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of Medical and Scientific Communications.

KJT Group
Sep 9th, 2024
KJT Welcomes Melissa Usseglio, Senior Vice President of Client Strategy

KJT is thrilled to announce the hiring of Melissa Usseglio as Senior Vice President of Client Strategy.

MR Web
May 30th, 2024
Daily Research News Online

US healthcare insights and consulting firm KJT has appointed Marilisa Beatty as a Vice President of Qualitative Research.

KJT Group
May 6th, 2024
Insights from the Exam Room: Decode the Conversation with DialogueDx

KJT Group'll introduce DialogueDx, its innovative solution which captures authentic conversations and offers deeper insights than traditional market research methods - leveraging generative AI to analyze these interactions at scale.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for KJT right now.

Find jobs on Simplify and start your career today

We update KJT's jobs every few hours, so check again soon! Browse all jobs →